2023 Agenda
Friday, October 6
Time
Event
7:00 am – Villard Foyer
Registration & Morning Coffee
8:20 am – Villard Ballroom
Welcome Back
Sara Jane Demy, Founder & CEO, Demy-Colton
8:30 am – Villard Ballroom
Opening “Big Think” Plenary Session
A Fireside Chat with Andy Plump:
What Will It Take to Deliver Cures to Society
Our unprecedented knowledge of human biology and disease is unlocking the potential to treat—and even cure—devastating diseases like never before. Simultaneously, innovations in data, digital and technology are revolutionizing our ability to discover, develop and deliver transformational medicines to patients. Explore what it will take to leverage the powerful technical tools at our disposal to bring the next generation of transformational medicines to patients.
Interviewer:
Seema Kumar, CEO, Cure
Interviewee:
Andy Plump, MD, PhD, President of R&D, Takeda
9:30 am
Adams/Kennedy I/Kennedy II
Presenting Companies
9:30 am – 12:30 pm
Louis/Stanford/Rutherford
One-To-Ones
10:30 am – Holmes I
Dialogue 4A
Oncology:
New Tactics to Turn Off Cancer
Moderator:
Jay Campbell, Managing Director, Clinical Accelerator & Venture Fund, Cancer Research Institute (CRI)
Panelists:
Roy de Souza, CEO, BreakBio
Michael Goldberg, PhD, CEO, SURGE Therapeutics
Anthony Johnson, CEO, Kodikaz
Wyatt J. McDonnell, PhD, CEO, Infinimmune
Mani Mohindru, PhD, CEO & Director, Novasenta
10:30 am – Holmes II
Dialogue 4B
Seeding the Future:
Financing Tech and Bio for Mind-blowing Breakthroughs
Moderator:
George Santo, Executive Director – Middle Market Life Sciences Commercial Banking, JPMorgan
Panelists:
Milad Alucozai, DrPH, Head, Bio and Deep Tech, BoxOne Ventures
Laurence Blumberg, MD, Biotechnology Executive; Lecturer, Weill Cornell Medicine
Olga Danilchanka, PhD, Principal, MRL Ventures Fund, Merck
Kayj Shannon, Venture Partner, Alix Ventures
11:15 am
Adams/Kennedy I/Kennedy II
Presenting Companies
12:30 pm – Villard Ballroom
“Big Think” Lunch Plenary
Mavericks:
Navigating the Biotech Landscape in a Difficult Market
Moderator:
Tim Opler, PhD, Managing Director, Global Healthcare Group, Stifel
Panelists:
Sal Saraceno, Managing Director, Healthcare Investment, Capital One
Brad Sitko, Chief Investment Officer, XOMA
Robert Williamson, President & COO, Triumvira
Hanadie Yousef, PhD, CEO & Co-Founder, Juvena
2:00 pm
Adams/Kennedy I/Kennedy II
Presenting Companies
2:00 pm – 3:45 pm
Louis/Stanford/Rutherford
One-To-Ones
3:00 pm – Holmes I
Dialogue 5A
Alzheimer’s Disease:
A Brighter Horizon – Are We Turning the Corner on This Intractable Disease
Moderator:
Virginia Amann, Founder/Shareholder ENTENTE Network
Panelists:
Jonathan Behr, PhD, Partner, Dementia Discovery Fund (DDF)
Marc Jones, CEO, Altoida
Brent Vaughan, CEO, Cognito
3:00 pm – Holmes II
Dialogue 5B
Infectious Disease:
From Neglect to Respect Made Possible by New Technologies
Moderator:
Steve Brozak, DMH, Managing Partner & President, WBB Securities
Panelists:
Rick Bright, PhD, Pandemic Prevention & Response
Steven Damon, CEO, Micron Biomedical
Elizabeth Kavaler, MD, Founding Partner, Total Urology Care of New York
Karim Lalji, CEO, Microbion
3:45 pm – Villard Ballroom
Closing “Big Think" Plenary
Heard Around the Street:
What’s Buzzing in Biotech
Moderator:
Kimberly Ha, CEO & Founder, KKH Advisors
Panelists:
Max Bayer, Reporter, Fierce Biotech
Hilary Brueck, Correspondent, Insider
Julianna LeMieux, PhD, Deputy Editor in Chief, GEN
Sony Salzman, Coordinating Producer, Medical Unit, ABC News
5:00 pm – Villard Foyer
Closing Reception